Pharmaceutical Preparations · DE · CIK 1703647
Korro Bio discovers, develops, and commercializes RNA-editing genetic medicines for various diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 10, 2026: 9 insiders bought $20.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Yang RickTenPercentOwner | Buy | 207,100 | $11.11 | $2.3M |
| Mar 10, 2026 | Sandell Scott DTenPercentOwner | Buy | 207,100 | $11.11 | $2.3M |
| Mar 10, 2026 | New Enterprise Associates 17, L.P.TenPercentOwner | Buy | 207,100 | $11.11 | $2.3M |
| Mar 10, 2026 | Chang CarmenTenPercentOwner | Buy | 207,100 | $11.11 | $2.3M |
| Mar 10, 2026 | Baskett ForestTenPercentOwner | Buy | 207,100 | $11.11 | $2.3M |
| Mar 10, 2026 | Mathers Edward TTenPercentOwner | Buy | 207,100 | $11.11 | $2.3M |
| Mar 10, 2026 | Makhzoumi MohamadTenPercentOwner | Buy | 207,100 | $11.11 | $2.3M |
| Mar 10, 2026 | Walker Paul EdwardTenPercentOwner | Buy | 207,100 | $11.11 | $2.3M |
| Mar 10, 2026 | Florence Anthony A. Jr.TenPercentOwner | Buy | 207,100 | $11.11 | $2.3M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.